We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$198B
AUM Growth
+$712M
Cap. Flow
-$14.4B
Cap. Flow %
-7.28%
Top 10 Hldgs %
21.74%
Holding
10,995
New
1,488
Increased
3,476
Reduced
3,726
Closed
2,170

Sector Composition

Rank Sector Weight
1 Healthcare 1.22%
2 Technology 1.15%
3 Consumer Discretionary 1.1%
4 Financials 1.05%
5 Communication Services 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTV
10201
DELISTED
VERITIV CORPORATION
VRTV
-15,317
Closed -$844K
GHL
10202
DELISTED
Greenhill & Co., Inc.
GHL
-49,434
Closed -$1.37M
AVTA
10203
DELISTED
Avantax, Inc. Common Stock
AVTA
-33,496
Closed -$525K
CCF
10204
DELISTED
Chase Corporation
CCF
-10,138
Closed -$847K
NXGN
10205
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-53,411
Closed -$787K
NEWR
10206
DELISTED
New Relic, Inc.
NEWR
-47,516
Closed -$1.66M
NEWR
10207
PUT
DELISTED
New Relic, Inc.
NEWR
-15,800
Closed -$446K
AVID
10208
DELISTED
Avid Technology Inc
AVID
-109,986
Closed -$569K
CYTO
10209
DELISTED
Altamira Therapeutics Ltd
CYTO
0
-$36K
CYTO
10210
PUT
DELISTED
Altamira Therapeutics Ltd
CYTO
0
-$13K
LTRPA
10211
PUT
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
-12,400
Closed -$187K
CIR
10212
DELISTED
CIRCOR International, Inc
CIR
-14,378
Closed -$884K
HCCI
10213
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
-17,012
Closed -$267K
NATI
10214
PUT
DELISTED
National Instruments Corp
NATI
-22,500
Closed -$693K
PRTK
10215
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-47,237
Closed -$744K
INFI
10216
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-93,061
Closed -$229K
WWE
10217
DELISTED
World Wrestling Entertainment
WWE
-68,321
Closed -$1.4M
QUOT
10218
DELISTED
Quotient Technology Inc
QUOT
-94,494
Closed -$1.04M
NUVA
10219
DELISTED
NuVasive, Inc.
NUVA
-98,554
Closed -$7.15M
FRBK
10220
DELISTED
Republic First Bancorp Inc
FRBK
-66,835
Closed -$558K
MTEM
10221
CALL
DELISTED
Molecular Templates, Inc.
MTEM
-72
Closed -$5K
KDNY
10222
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-9,916
Closed -$560K
SPPI
10223
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-117,721
Closed -$658K
AJRD
10224
CALL
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-84,200
Closed -$1.51M
AJRD
10225
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-69,958
Closed -$1.38M

Similar funds

Jeff Yass's Q1 2017 Portfolio in Review

As of Q1 2017, Jeff Yass held 10,995 positions worth $198B, up 0.36% from $197B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jeff Yass withdrew a net $14.4B in Q1 2017, closing 2,170 positions and reducing 3,726 holdings. Its most notable exit was Air Products & Chemicals, an estimated $219M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.2% of assets, down from 1.2% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Jeff Yass opened a new position in iShares MSCI EAFE ETF worth $131M.

  • Jeff Yass's largest Q1 2017 buy was iShares MSCI EAFE ETF: 2,100,985 shares worth $131M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $879M increase.
  • Jeff Yass's biggest Q1 2017 reduction was Apple, cutting an estimated $1.82B.
  • Jeff Yass fully exited Air Products & Chemicals in Q1 2017, selling an estimated $219M.
  • Jeff Yass's ten largest holdings make up 22% of its $198B portfolio in Q1 2017.
  • Jeff Yass opened 1,488 new positions and closed 2,170 in Q1 2017.
  • Jeff Yass's portfolio value rose 0.36% quarter-over-quarter to $198B.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.